Blog Archives

Featured, Investing, Market Pulse, News,

‘Pharma Bro’ Martin Shkreli Buys $KBIO – Stock Pops 700% After-hours

Martin Shkreli (aka Pharma Bro) is an American hedge fund manager, specializing in healthcare businesses, and is a co-founder of MSMB Capital Management. In September 2015, Shkreli was criticized when Turing Pharmaceuticals obtained the manufacturing license for Daraprim, and raised its price by 5,455 percent (from $13.50 to $750 per

0no comment